Repro Med Systems Inc (REPR) financial statements (2021 and earlier)

Company profile

Business Address 24 CARPENTER RD
CHESTER, NY 10918
State of Incorp. NY
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27,3155,8713,7393,3134,2022,5572,227
Cash and cash equivalents27,3155,8713,7393,3134,2022,5572,227
Receivables2,5733,2351,4261721,3501,6241,745
Inventory, net of allowances, customer advances and progress billings6,8302,3882,1041,3541,0401,227819
Inventory6,8302,3882,1041,3541,0401,227819
Prepaid expense808387247176265241246
Deposits current assets     260259
Other undisclosed current assets  1,5181,764261  
Total current assets:37,52611,8819,0336,7807,1195,9085,295
Noncurrent Assets
Operating lease, right-of-use asset237374
Property, plant and equipment1,1686128599329971,161839
Intangible assets, net (including goodwill)84480763242724818143
Intangible assets, net (excluding goodwill)84480763242724818143
Deferred income tax assets125 
Other noncurrent assets20202031313174
Deferred tax assets, net1    
Other undisclosed noncurrent assets 188    (43)
Total noncurrent assets:2,3932,0011,5121,3911,2761,373913
TOTAL ASSETS:39,91913,88210,5458,1708,3947,2816,209
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5222,2641,5801,3671,085669749
Accounts payable625573453772308243247
Accrued liabilities2,6101,297689417499304263
Employee-related liabilities28719042217714912273
Taxes payable 20517 129 166
Debt3142     
Deferred lease income  4
Deferred revenue and credits22222222
Other undisclosed current liabilities141      
Total current liabilities:3,6662,4061,5841,3891,108692772
Noncurrent Liabilities
Long-term debt and lease obligation96239     
Finance lease, liability 3
Operating lease, liability96237
Liabilities, other than long-term debt   105168316245
Deferred revenue and credits22456790
Deferred tax liabilities, net 82123249155
Other undisclosed noncurrent liabilities(96)      
Total noncurrent liabilities:96239 105168316245
Total liabilities:3,7622,6461,5841,4941,2761,0081,017
Stockholders' equity
Stockholders' equity attributable to parent36,15711,2368,9616,6767,1186,2735,192
Common stock467422409406405403389
Treasury stock, value(3,844)(344)(344)(344)(247)(166)(142)
Additional paid in capital35,8816,2934,5954,1303,9683,8553,512
Deferred compensation equity    (28)(56)(52)
Retained earnings3,6534,8654,3002,4853,0202,2371,484
Total stockholders' equity:36,15711,2368,9616,6767,1186,2735,192
TOTAL LIABILITIES AND EQUITY:39,91913,88210,5458,1708,3947,2816,209

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
Revenues24,17623,16317,35412,29412,24711,2458,699
Revenue, net12,29412,24711,2458,699
Cost of revenue(9,240)(8,309)(6,543)(4,724)(4,644)(4,557)(3,622)
Cost of goods and services sold(9,240)(8,309)(6,543)(4,724)(4,644)(4,557)(3,389)
Gross profit:14,93614,85410,8107,5707,6036,6885,077
Operating expenses(16,191)(14,268)(9,646)(8,306)(6,422)(5,540)(4,069)
Operating income (loss):(1,255)5861,165(736)1,1811,1471,008
Nonoperating income (expense)61637(39)(35)(72)3
Investment income, nonoperating     67
Foreign currency transaction gain (loss), before tax2(18)(21)(41)(26)(78)(0)
Other nonoperating income (expense)4281283(9)  
Interest and debt expense(0)(0) (2)(3)(1)(5)
Other undisclosed income from continuing operations before equity method investments, income taxes0485    
Income (loss) from continuing operations before equity method investments, income taxes:(1,194)6961,177(777)1,1431,0751,006
Other undisclosed income from continuing operations before income taxes      5
Income (loss) from continuing operations before income taxes:(1,194)6961,177(777)1,1431,0751,010
Income tax expense (benefit)(18)(132)(266)242(360)(321)(307)
Net income (loss) available to common stockholders, diluted:(1,212)564911(535)783753703

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
Net income (loss):(1,212)564911(535)783753703
Comprehensive income (loss), net of tax, attributable to parent:(1,212)564911(535)783753703

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: